References
- Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am 2006; 20: 507–544.
- Kwon-Chung KJ, Boekhout T, Fell JW, Diaz M. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon 2002; 51: 804–806.
- Granados DP, Castañeda E. Influence of climatic conditions on the isolation of members of the Cryptococcus neoformans species complex from trees in Colombia from 1992–2004. FEMS Yeast Res 2006; 6: 636–644.
- Meyer W, Castañeda A, Jackson S, . Molecular typing of Ibero-American Cryptococcus neoformans isolates. Emerg Infect Dis 2003; 9: 189–195.
- Butler MI, Poulter RTM. The PRP8 inteins in Cryptococcus are a source of phylogenetic and epidemiological information. Fungal Genet Biol 2005; 42: 452–463.
- Litvintseva AP, Lin X, Templeton I, Heitman J, Mitchell TG. Many globally isolated AD hybrid strains of Cryptococcus neoformans originated in Africa. PLoS Pathog 2007; 3: 1109–1117.
- Bovers M, Hagen F, Kuramae EE, Boekhout T. Six monophyletic lineages identified within Cryptococcus neoformans and Cryptococcus gattii by multi-locus sequence typing. Fungal Genet Biol 2008; 45: 400–421.
- Boekhout T, Theelen B, Diaz M, . Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology 2001; 147: 891–907.
- Barriga Angulo G, Asumir Escorza C, Mercado González NF. Actualidades y tendencias en la etiología de las meningoencefalitis causadas por hongos y bacterias (1980–2004). Rev Mex Patol Clin 2005; 52: 240–245.
- Castañón-Olivares LR, Arreguín-Espinosa R, Ruiz-Palacios y Santos G, López-Martínez R. Frequency of Cryptococcus species and varieties in México and their comparison with some Latin American countries. Rev Lat-Amer Microbiol 2000; 42: 35–40.
- Staib F, Seibold M, Antweiler E, Frohlich B. Staib agar supplemented with a triple antibiotic combination for the detection of Cryptococcus neoformans in clinical specimens. Mycoses 1989; 32: 448–454.
- Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic médium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 1982; 15: 535–537.
- Dufait R, Velho R, De Vroey C. Rapid identification of the two varieties of Cryptococcus neoformans by D-proline assimilation. Mykosen 1987; 30: 483.
- National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard (M27-A2), 2nd. Wayne Pennsylvania: Clinical and Laboratory Standars Institute, 2002.
- Feldmesser M, Kress Y, Mednick A, Casadevall A. The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. J Infect Dis 2000; 182: 1791–1795.
- Aller AI, Martín–Mazuelos E, Lozano F, . Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob Agents Chemother 2000; 44: 1544–1548.
- Franzot SP, Hamdan JS. In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs. Antimicrob Agents Chemother 1996; 40: 822–824.
- Rex JH, Pfaller A, Galgiani JN, . Development of interpretative breakpoints for antifungal susceptibility testing: conceptual framework an analysis of in vitro – in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis 1997; 24: 325–347.
- Bovers M, Hagen F, Kuramae EE, . Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii. FEMS Yeast Res 2006; 6: 599–607.